MARLBOROUGH, Mass., June 27,
2023 /PRNewswire/ -- Boston Scientific Corporation
(NYSE: BSX) announced today the election of Dr. Jessica L. Mega and Susan E. Morano to its board of directors, each
effective immediately.
Dr. Mega is the co-founder of Verily Life Sciences LLC, a
subsidiary of Alphabet Inc. focused on life sciences and
healthcare, and was the company's chief medical and scientific
officer from 2015 to January 2023.
Prior to joining Verily, Dr. Mega served as a cardiologist at
Brigham & Women's Hospital from 2008 to 2015. Dr. Mega also
served as a faculty member at Harvard Medical
School and as a senior investigator with the TIMI Study
Group, where she led international trials evaluating novel
cardiovascular therapies and directed the genomics program. She
currently is a director of Danaher Corporation. Dr. Mega received
her B.A. from Stanford University, her
M.D. from Yale University School of
Medicine, and her M.P.H. from Harvard
School of Public Health.
Ms. Morano held the role of vice president, Business Development
and Strategic Operations, Johnson & Johnson MedTech from 2020
through February 2023. Prior to that,
she served as vice president, Business Development, Johnson &
Johnson Medical Devices, beginning in 2012, with responsibility for
licensing, acquisitions and divestitures for its Medical Devices
Group. During her time at Johnson & Johnson, Ms. Morano also
held several positions within six operating companies, primarily in
the finance and business development functions, and as a member of
the MedTech Leadership Team. Ms. Morano received her B.S. from
Villanova University and her M.B.A.
from Columbia Business School.
"We are pleased to expand our board of directors with two highly
qualified executives from different sectors of the healthcare
industry," said Mike Mahoney, chief
executive and chairman of the board, Boston Scientific. "Jessica
and Susan are accomplished leaders passionate about advancing
patient care and experienced in bringing innovative technologies to
market, and we look forward to their contributions as board members
as Boston Scientific continues to grow and meet our stakeholder
commitments."
About Boston Scientific
Boston Scientific transforms
lives through innovative medical solutions that improve the health
of patients around the world. As a global medical technology
leader for more than 40 years, we advance science for life by
providing a broad range of high performance solutions that address
unmet patient needs and reduce the cost of healthcare. For more
information, visit www.bostonscientific.com and connect on Twitter
and Facebook.
CONTACTS
|
|
|
Media:
|
|
Investors:
|
Emily
Anderson
|
|
Lauren Tengler
|
617-515-2000
(office)
|
|
508-683-4479
(office)
|
Media
Relations
|
|
Investor
Relations
|
Boston Scientific
Corporation
|
|
Boston Scientific
Corporation
|
Emily.Anderson2@bsci.com
|
|
BSXInvestorRelations@bsci.com
|
|
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/boston-scientific-elects-dr-jessica-l-mega-and-susan-e-morano-to-board-of-directors-301864104.html
SOURCE Boston Scientific Corporation